{"organizations": [], "uuid": "646ee6a6967431efe7b3d0f790d16ea3d30cc2b0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novoheart-signs-agreement-with-sum/brief-novoheart-signs-agreement-with-sumocor-to-develop-therapeutics-for-heart-failure-idUSFWN1Q41AC", "country": "US", "domain_rank": 408, "title": "BRIEF-Novoheart Signs Agreement With Sumocor To Develop Therapeutics For Heart Failure", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T16:18:00.000+02:00", "replies_count": 0, "uuid": "646ee6a6967431efe7b3d0f790d16ea3d30cc2b0"}, "author": "", "url": "https://www.reuters.com/article/brief-novoheart-signs-agreement-with-sum/brief-novoheart-signs-agreement-with-sumocor-to-develop-therapeutics-for-heart-failure-idUSFWN1Q41AC", "ord_in_thread": 0, "title": "BRIEF-Novoheart Signs Agreement With Sumocor To Develop Therapeutics For Heart Failure", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "novoheart holdings inc", "sentiment": "none"}, {"name": "heart failure reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novoheart holdings inc - co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 14, 2018 / 2:22 PM / in 4 minutes BRIEF-Novoheart Signs Agreement With Sumocor To Develop Therapeutics For Heart Failure Reuters Staff Feb 14 (Reuters) - Novoheart Holdings Inc: * NOVOHEART SIGNS AGREEMENT WITH SUMOCOR TO DEVELOP NOVEL THERAPEUTICS FOR HEART FAILURE * NOVOHEART HOLDINGS INC - CO, THROUGH ITS U.S. UNIT, HAS ENTERED INTO A COMMERCIAL AGREEMENT WITH SUMOCOR LLC * NOVOHEART - AS PER AGREEMENT, CO WILL TEST SUMOCOR‘S CANDIDATE THERAPEUTICS IN 3 PHASES ON CO‘S MYHEART PLATFORM OF HUMAN BIOENGINEERED HEART CONSTRUCTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-14T16:18:00.000+02:00", "crawled": "2018-02-14T16:34:02.004+02:00", "highlightTitle": ""}